| 1 |
Cappadona C, Rimoldi V, Paraboschi EM, Asselta R. Genetic susceptibility to severe COVID-19. Infect Genet Evol 2023;110:105426. [PMID: 36934789 DOI: 10.1016/j.meegid.2023.105426] [Reference Citation Analysis]
|
| 2 |
Mohamed AA, Alrohaimi AH, Sayed Abdelgeliel A, Albogami S, Jafri I, Fayad E, Mohamed N, Nassar NA, Adaroas AS, Eldeeb HH, Abdel Halim A, Ramadan A, Elnagar RM, Abdelghafour RAM, Mohamed AY, Mahmoud MO, El-Kasses A, El-Sayed M, Mohammed MA, Alwaleed EA, Mousa S, Abdel Salam S, Abd El Salam SM. The Impact of LEP rs7799039 Polymorphism and Obesity on the Severity of Coronavirus Disease-19. Diabetes Metab Syndr Obes 2023;16:515-22. [PMID: 36852180 DOI: 10.2147/DMSO.S391869] [Reference Citation Analysis]
|
| 3 |
Nejat R, Torshizi MF, Najafi DJ. S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review. Vaccines (Basel) 2023;11. [PMID: 36851081 DOI: 10.3390/vaccines11020204] [Reference Citation Analysis]
|
| 4 |
Dieter C, de Almeida Brondani L, Lemos NE, Schaeffer AF, Zanotto C, Ramos DT, Girardi E, Pellenz FM, Camargo JL, Moresco KS, da Silva LL, Aubin MR, de Oliveira MS, Rech TH, Canani LH, Gerchman F, Leitão CB, Crispim D. Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19. Genes (Basel) 2022;14. [PMID: 36672770 DOI: 10.3390/genes14010029] [Reference Citation Analysis]
|
| 5 |
Rabaan AA, Mutair AA, Aljeldah M, Shammari BRA, Sulaiman T, Alshukairi AN, Alfaresi M, Al-Jishi JM, Al Bati NA, Al-Mozaini MA, Bshabshe AA, Almatouq JA, Abuzaid AA, Alfaraj AH, Al-Adsani W, Alabdullah M, Alwarthan S, Alsalman F, Alwashmi ASS, Alhumaid S. Genetic Variants and Protective Immunity against SARS-CoV-2. Genes (Basel) 2022;13. [PMID: 36553622 DOI: 10.3390/genes13122355] [Reference Citation Analysis]
|
| 6 |
de Andrade CC, Silva ATP, Vasconcelos LRS, Oliveira PRS, de Souza CDF, da Costa Armstrong A, do Carmo RF. A Polymorphism in the TMPRSS2 Gene Increases the Risk of Death in Older Patients Hospitalized with COVID-19. Viruses 2022;14. [PMID: 36423166 DOI: 10.3390/v14112557] [Reference Citation Analysis]
|
| 7 |
Zaki Mahdi N, A. M. K, Sahib Khalil N. Assessing the potential correlation of polymorphisms in the TMPRSS2 gene with severity of COVID 19 patients. Biomedicine 2022;42:1034-1039. [DOI: 10.51248/.v42i5.2279] [Reference Citation Analysis]
|
| 8 |
Ji X, Chen B, Ze B, Zhou W. Human genetic basis of severe or critical illness in COVID-19. Front Cell Infect Microbiol 2022;12:963239. [DOI: 10.3389/fcimb.2022.963239] [Reference Citation Analysis]
|
| 9 |
Mohammadi M, Rahimi AA, Salehi-vaziri M, Sharifnia F, Mehrjerdi EK, Karimipoor M. Correlation of ACE2 and TMPRSS2 expression levels in nasopharyngeal swab samples of COVID-19 patients with disease severity.. [DOI: 10.21203/rs.3.rs-2048684/v1] [Reference Citation Analysis]
|
| 10 |
de Sá NBR, Neira-goulart M, Ribeiro-alves M, Perazzo H, Geraldo KM, Ribeiro MPD, Cardoso SW, Grinsztejn B, Veloso VG, Capão A, Siqueira MM, de Lima Bezerra OC, Garcia CC, Gomes LR, da Silva Cazote A, de Almeida DV, Giacoia-gripp CBW, Côrtes FH, Morgado MG, Bach H. Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/9082455] [Reference Citation Analysis]
|
| 11 |
Khare K, Pandey R. Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key. Front Immunol 2022;13:973070. [DOI: 10.3389/fimmu.2022.973070] [Reference Citation Analysis]
|
| 12 |
Ishak A, Mehendale M, AlRawashdeh MM, Sestacovschi C, Sharath M, Pandav K, Marzban S. The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature. Gene 2022;836:146674. [PMID: 35714803 DOI: 10.1016/j.gene.2022.146674] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
